Pfizer gives lyme vaccine a fifth dose — will it boost protection?
NCT ID NCT07500506
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a fifth dose of Pfizer's Lyme disease vaccine (VLA15) is safe and boosts immunity in people who already received four doses. About 1,700 healthy volunteers aged 7 and older will get either the vaccine or a saltwater shot. Researchers will compare side effects and antibody levels over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- VLA15 (Lyme disease vaccine)
- What this could lead to
- If successful, this could show that a booster dose of the Lyme disease vaccine provides continued protection against Lyme disease.
- What could go wrong
- This is a Phase 3 trial, but it only tests immune response and safety, not whether the vaccine actually prevents Lyme disease. The vaccine may not work as well in real-world conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYME DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Allegheny Health and Wellness Pavilion
RECRUITINGErie, Pennsylvania, 16506, United States
-
Altoona Center For Clinical Research
RECRUITINGDuncansville, Pennsylvania, 16635, United States
-
Amherst Family Practice, P.C.
NOT_YET_RECRUITINGWinchester, Virginia, 22601, United States
-
Central Erie Primary Care
RECRUITINGErie, Pennsylvania, 16508, United States
-
Diex Recherche Inc. Division Sherbrooke
RECRUITINGSherbrooke, Quebec, J1L 0H8, Canada
-
Frontier Clinical Research, LLC
RECRUITINGScottdale, Pennsylvania, 15683, United States
-
Frontier Clinical Research, LLC
RECRUITINGSmithfield, Pennsylvania, 15478, United States
-
Hunterdon Medical Center
NOT_YET_RECRUITINGFlemington, New Jersey, 08822, United States
-
Milestone Research Inc.
NOT_YET_RECRUITINGLondon, Ontario, N5W 6A2, Canada
-
Northeast Clinical Trials Group
RECRUITINGScranton, Pennsylvania, 18510, United States
-
Northern Light Eastern Maine Medical Center
NOT_YET_RECRUITINGBangor, Maine, 04401, United States
-
Northern Light Family Medicine and Residency Center
NOT_YET_RECRUITINGBangor, Maine, 04401, United States
-
Preferred Primary Care Physicians
NOT_YET_RECRUITINGUniontown, Pennsylvania, 15401, United States
-
Preferred Primary Care Physicians, Preferred Clinical Research (Ofc 18)
RECRUITINGPittsburgh, Pennsylvania, 15236, United States
-
Preferred Primary Care Physicians, Preferred Clinical Research - St.Clair
NOT_YET_RECRUITINGPittsburgh, Pennsylvania, 15243, United States
-
Robert Packer Hospital
RECRUITINGSayre, Pennsylvania, 18840, United States
-
Smith Allergy & Asthma Specialists
RECRUITINGHorseheads, New York, 14845, United States
-
Smith Allergy and Asthma Specialists
RECRUITINGCortland, New York, 13045, United States
-
Stouffville Medical Research Institute Inc.
NOT_YET_RECRUITINGStouffville, Ontario, L4A 1H2, Canada
-
The University of Vermont Medical Center Inc.
NOT_YET_RECRUITINGBurlington, Vermont, 05401, United States
-
University of Massachusetts Chan Medical School
RECRUITINGWorcester, Massachusetts, 01655, United States
-
Velocity Clinical Research, Providence
NOT_YET_RECRUITINGEast Greenwich, Rhode Island, 02818, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune cell tracking could sharpen lyme disease diagnosis
- Lyme disease and parenthood: a hidden struggle revealed
- Lyme disease in pregnancy: new study tracks baby brain development
- New blood test aims to spot lyme disease in kids faster and more accurately
- New mRNA vaccine could stop lyme disease in its tracks
- Could a single pill stop lyme disease before it starts?